Novian Health

  • About Us
    • Overview
    • Management
    • Board Of Directors
    • Investors
  • Research & Products
    • Novilase® Breast Therapy
    • Clinical Trials & Registries
    • Publications
    • Intellectual Property
  • News
    • News & Press Releases
    • Media Coverage
    • Upcoming Events
  • Contact
    • Careers

Novian Health Awarded New Patent for Breast Cancer Treatment Technology (05 Dec 2013)

December 5, 2013 by Novian Health

December 5 2013 Contact: Liz Dowling, (415) 388-2794 Dowling & Dennis Public Relations E-mail:Liz@DowlingDennis.net CHICAGO–Novian Health, developer of Novilase® Breast Therapy, announced the company has received a Notice of Allowance for a new patent.The U.S. patent,Application No. 12/778,580,covers interstitial laser therapy in combination with interstitial brachytherapy treatment. The technology could make breast cancer treatment more […]

Filed Under: Press Release 2013

Novian Health Venture Capital Activity in 1Q 2013 for Breast Cancer Clinical Trials (18 April 2013)

April 18, 2013 by Novian Health

Chicago area last in venture capital activity in 1Q Venture capital activity in the Chicago area slowed to a crawl in the first quarter of the year, according to data released Thursday by Dow Jones VentureSource. Chicago-area companies raised $20 million in eight deals in the quarter. This was a significant decrease from the first […]

Filed Under: Press Release 2013

Novian Health Closes $11 Million in Funding for Breast Cancer Clinical Trials (04 Feb 2013)

February 4, 2013 by Novian Health

CHICAGO – Novian Health, developer of Novilase® Breast Therapy, announced today that it has successfully completed a funding round totaling $11 million. iNetworks, LLC (Pittsburgh, Pa) led the round of Series A Preferred share financing, which also included prior and new investors. Proceeds from the funding will primarily be used to conduct Novian’s multicenter clinical […]

Filed Under: Press Release 2013

Recent Posts

  • Novian Health Earns New Product Innovation Award for Novilase Breast Therapy (6 December 2022)
  • Novian Health Gains FDA Breakthrough Designation for Novilase Breast Therapy (28 September 2021)
  • Novian Health Inc. Announces the Second Close of Convertible Note Financing (23 August 2021)
  • Novian Health Inc. Announces the First Close of Convertible Note Financing (28 July 2021)
  • Novian Health to Present at the Cavendish Global Summit on February 25, 2021 (12 February 2021)

ARCHIVES

  • December 2022
  • September 2021
  • August 2021
  • July 2021
  • February 2021
  • September 2020
  • June 2020
  • September 2019
  • July 2019
  • June 2019
  • December 2015
  • December 2014
  • September 2014
  • May 2014
  • December 2013
  • April 2013
  • February 2013
  • April 2012
  • October 2011
  • September 2011
  • July 2011
  • November 2010
  • December 2009
  • November 2009
  • October 2009
  • May 2009
  • June 2008
  • March 2008
  • October 2007
  • June 2007

Categories

  • Archives
  • Press Release 2011
  • Press Release 2012
  • Press Release 2013
  • Press Release 2014
  • Press Release 2015
  • Press Release 2019
  • Press Release 2020
  • Press Release 2021
  • Press Release 2022

CONTACT US

Novian Health Inc.
(Headquarters)
Novian Health Inc.
(Manufacturing)
222 W Merchandise Mart Plaza
Suite 1230
Chicago, Illinois 60654
1205 E State Avenue
Tonganoxie, KS 66086
Office: 312-266-7200 Office: 312-266-7200
Fax: 312-266-7202 Fax: 312-266-7202
Email: info@novianhealth.com Email: info@novianhealth.com

    

LATEST NEWS

  • Novian Health Earns New Product Innovation Award for Novilase Breast Therapy (6 December 2022)
  • Novian Health Gains FDA Breakthrough Designation for Novilase Breast Therapy (28 September 2021)
  • Novian Health Inc. Announces the Second Close of Convertible Note Financing (23 August 2021)
  • Novian Health Inc. Announces the First Close of Convertible Note Financing (28 July 2021)
  • Novian Health to Present at the Cavendish Global Summit on February 25, 2021 (12 February 2021)

Copyright © 2023 Novian Health. All Rights Reserved. Powered by